Anti-nucleocapsid antibody levels following initial and repeat SARS-CoV-2 infections in a cohort of long-term care facility residents in England (VIVALDI).
Oliver T StirrupGokhan TutMaria KrutikovDavid BoneTara LancasterBorscha AzmiIgor MonakhovPaul A H MossAndrew C HaywardAndrew CopasLaura J ShallcrossPublished in: Wellcome open research (2024)
We found similar levels of anti-nucleocapsid antibody in residents and staff of LTCFs. Repeat infection and infection with an Omicron strain were associated with higher peak values. There was evidence of waning of anti-nucleocapsid antibody levels over time.